Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of Zanamivir on H5N1 infection in mice

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1592-1596

  Gubareva, Larisa V ^b   McCullers, Jonathan A ^b   Bethell, Richard C ^b   Webster, Robert G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ZANAMIVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; EPIDEMIC; FEMALE; HONG KONG; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; CHICK EMBRYO; FEMALE; GUANIDINES; HONG KONG; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; PYRANS; SIALIC ACIDS; VIRULENCE; VIRUS REPLICATION; ZANAMIVIR;

EID: 0031766022     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314515     Document Type: Article

References (21)

1. De Jong JC, Claas ECJ, Osterhaus ADME, Webster RG, Lim WL. A pandemic warning? [letter] Nature 1997;389:554.
2. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998;279:393-6.
3. Claas ECJ, Osterhaus ADME, van Beek R, et al. Human influenza A (H5N1) virus related to a highly pathogenic avian influenza virus. Lancet 1998;351:472-7.
4. Webster RG. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch Virol 1997;13(suppl): 105-13.
5. Hayden FG. Amantadine and rimantadine - clinical aspects. In: Richman DD, ed. Antiviral drug resistance. New York: John Wiley & Sons, 1996:59-77.
6. Hay A, Hayden FG, Arden N, Jolson HM, Laver G, Zimmerman H. Workshop 5: antivirals for the pandemic situation. J Infect Dis 1997;176(suppl 1):S83-4.
7. Hayden FG, Osterhaus ADME, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997;337:874-80.
8. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 1996;275:295-9.
9. Ryan DM, Ticehurst J, Dempsey MH. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob Agents Chemother 1995;39:2583-4.
10. McCauley JW, Pullen LA, Forsyth M, Penn CR, Thomas GP. 4-guanidino-Neu5Ac2en fails to protect chickens from infection with highly pathogenic avian influenza virus. Antiviral Res 1995;27:179-86.
11. Gubareva LV, Penn,CR, Webster RG. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 1995;212:323-30.
12. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate. Anal Biochem 1979;94:287-96.
13. Hayden FG, Cote KM, Douglas RG Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 1980;17:865-70.
14. Ryan DM, Ticehurst J, Dempsey MH, Penn CR. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob Agents Chemother 1994;38:2270-5.
15. von Itzstein M, Wu WY, Kok GB, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993;363:418-23.
16. Grunert RR, McGahen JW, Davies WL. The in vivo antiviral activity of 1-adamantanamine (amantadine). Virology 1965;26:262-9.
17. Kawaoka Y. Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: potential use as an animal model. J Virol 1991;65:3891-4.
18. Liu C, Eichelberger MC, Compans RW, Air GM. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 1995;69:1099-106.
19. Thomas GP, Forsyth M, Penn CR, McCauley JW. Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid. Antiviral Res 1994;24:351-6.
20. Gubareva LV, Bethell RC, Hart GJ, Murti KG, Penn CR, Webster RG. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J Virol 1996;70:1818-27.
21. Castrucci M, Kawaoka Y. Biologic importance of neuraminidase stalk length in influenza A virus. J Virol 1993;67:759-64.